Blood Screening Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Blood Screening Market size is expected to grow at an annual average of 11% during 2021-2027. Blood is a living tissue composed of liquid, in which numerous cells and proteins are suspended. A circulating fluid that contains red blood cells, white blood cells, and platelets. It provides oxygen and nutrients to the cells of the body through capillaries, arteries and veins. It also helps remove metabolic wastes and carbon dioxide from the body. A blood test is a medical process that tests blood for certain diseases or conditions.

The following segmentation are covered in this report:

By End User

• Blood Banks
• Hospitals

By Technology

• Nucleic Acid Amplification
• ELISA
• Rapid tests
• NGS

Company Profile

• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche
• Ortho Clinical Diagnostics
• BD
• DiaSorin S.p.A.
• Thermo Fisher Scientific Inc.
• Abbott
• QUOTIENT

Scope of the report

The research study analyses the Blood Screening Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Blood Screening Market Report

• What was the Blood Screening Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Blood Screening Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.